Perrone R D, Steinman T I, Beck G J, Skibinski C I, Royal H D, Lawlor M, Hunsicker L G
National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
Am J Kidney Dis. 1990 Sep;16(3):224-35. doi: 10.1016/s0272-6386(12)81022-5.
Assessment of glomerular filtration rate (GFR) with inulin is cumbersome and time-consuming. Radioisotopic filtration markers have been studied as filtration markers because they can be used without continuous intravenous (IV) infusion and because analysis is relatively simple. Although the clearances of 99mTc-diethylenetriamine-pentaacetic acid (DTPA), 169Yb-DTPA, and 125I-iothalamate have each been compared with inulin, rarely has the comparability of radioisotopic filtration markers been directly evaluated in the same subject. To this purpose, we determined the renal clearance of inulin administered by continuous infusion and the above radioisotopic filtration markers administered as bolus injections, simultaneously in four subjects with normal renal function and 16 subjects with renal insufficiency. Subjects were studied twice in order to assess within-study and between-study variability. Unlabeled iothalamate was infused during the second half of each study to assess its effect on clearances. We found that renal clearance of 125I-iothalamate and 169Yb-DTPA significantly exceeded clearance of inulin in patients with renal insufficiency, but only by several mL.min-1.1.73m-2. Overestimation of inulin clearance by radioisotopic filtration markers was found in all normal subjects. No differences between markers were found in the coefficient of variation of clearances either between periods on a given study day (within-day variability) or between the two study days (between-day variability). The true test variability between days did not correlate with within-test variability. We conclude that the renal clearance of 99mTc-DTPA, 169Yb-DTPA, or 125I-iothalamate administered as a single IV or subcutaneous injection can be used to accurately measure GFR in subjects with renal insufficiency; use of the single injection technique may overestimate GFR in normal subjects.
菊粉用于评估肾小球滤过率(GFR)既麻烦又耗时。放射性同位素滤过标记物已被作为滤过标记物进行研究,因为它们无需持续静脉输注即可使用,且分析相对简单。尽管已将99mTc - 二乙三胺五乙酸(DTPA)、169Yb - DTPA和125I - 碘肽酸盐的清除率分别与菊粉进行了比较,但很少在同一受试者中直接评估放射性同位素滤过标记物之间的可比性。为此,我们在4名肾功能正常的受试者和16名肾功能不全的受试者中,同时测定了持续输注的菊粉以及推注给药的上述放射性同位素滤过标记物的肾脏清除率。为评估研究内和研究间的变异性,对受试者进行了两次研究。在每次研究的后半段输注未标记的碘肽酸盐,以评估其对清除率的影响。我们发现,在肾功能不全的患者中,125I - 碘肽酸盐和169Yb - DTPA的肾脏清除率显著超过菊粉的清除率,但仅高出几mL·min-1·1.73m-2。在所有正常受试者中均发现放射性同位素滤过标记物高估了菊粉清除率。在给定研究日的不同时间段(日内变异性)或两个研究日之间(日间变异性),各标记物清除率的变异系数未发现差异。日间的实际测试变异性与测试内变异性不相关。我们得出结论,单次静脉注射或皮下注射给药的99mTc - DTPA、169Yb - DTPA或125I - 碘肽酸盐的肾脏清除率可用于准确测量肾功能不全受试者的GFR;单次注射技术可能会高估正常受试者的GFR。